Legal / IP

AstraZenecaBoehringer Ingelheim

Merck Loses Third Circuit Appeal as Court Upholds Medicare Drug Price Negotiations Under IRA

The U.S. Court of Appeals for the Third Circuit ruled against Merck & Co., Inc. (MSD; NYSE: MRK), rejecting the drugmaker's claim that Medicare drug price negotiations violate the First…

WuXi AppTec Wins Preliminary Injunction Against DoD 1260H Designation

WuXi AppTec Wins Preliminary Injunction Against DoD 1260H Designation

Novo Nordisk Sues Eli Lilly Over Alleged False Advertising of Zepbound and Mounjaro in GLP-1 Market

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Contact US
AlzeCure Pharma

AlzeCure Pharma’s Alzheimer’s Drug Candidate ACD856 Receives Global Patent Awards

NovartisNYSE: NVS

Sandoz Agrees to $265 Million Settlement in U.S. Generic Drug Antitrust Case

GSKNYSE: GSK

GSK and Peers Respond to FTC Criticism, Withdraw Patent Listings from US Orange Book

HKG: 2186Luye Pharma

Luye Pharma’s Paliperidone Palmitate NDA Avoids Patent Lawsuit, Clears Path for FDA Approval

Show More